{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:01:54Z","timestamp":1773788514427,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The COVID-19 outbreak represents a significant challenge to international health. Several studies have reported a substantial decrease in the number of patients attending emergency departments with acute coronary syndromes (ACS) and there has been a concomitant rise in early mortality or complications during the COVID-19 pandemic. A modified management system that emphasizes nearby treatment, safety, and protection, alongside a closer and more effective multiple discipline collaborative team was developed by our Chest Pain Center at an early stage of the pandemic. It was therefore necessary to evaluate whether the newly adopted management strategies improved the clinical outcomes of ACS patients in the early stages of the COVID-19 pandemic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Patients admitted to our Chest Pain Center from January 25th to April 30th, 2020 based on electronic data in the hospitals ACS registry, were included in the COVID-19 group. Patients admitted during the same period (25 January to 30 April) in 2019 were included in the pre-COVID-19 group. The characteristics and clinical outcomes of the ACS patients in the COVID-19 period group were compared with those of the ACS patients in the pre-COVID-19 group. Multivariate logistic regression analyses were used to identify the risk factors associated with clinical outcomes.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The number of patients presenting to the Chest Pain Center was reduced by 45% (<jats:italic>p<\/jats:italic>\u2009=\u20090.01) in the COVID-19 group, a total of 223 ACS patients were included in the analysis. There was a longer average delay from the onset of symptom to first medical contact (FMC) (1176.9\u00a0min vs. 625.2\u00a0min, <jats:italic>p<\/jats:italic>\u2009=\u20090.001) in the COVID-19 period group compared to the pre-COVID-19 group. Moreover, immediate percutaneous coronary intervention (PCI) (80.1% vs. 92.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.008) was performed less frequently on ACS patients in the COVID-19 group compared to the pre-COVID-19 group. However, more ACS patients received thrombolytic therapy (5.8% vs. 0.6%, <jats:italic>p<\/jats:italic>\u2009=\u20090.0052) in the COVID-19 group than observed in the pre-COVID-19 group. Interestingly, clinical outcome did not worsen in the COVID-19 group when cardiogenic shock, sustained ventricular tachycardia, ventricular fibrillation or use of mechanical circulatory support (MCS) were compared against the pre-COVID-19 group (13.5% vs. 11.6%, <jats:italic>p<\/jats:italic>\u2009=\u20090.55). Only age was independently associated with composite clinical outcomes (HR\u2009=\u20091.3; 95% CI 1.12\u20131.50, <jats:italic>p<\/jats:italic>\u2009=\u20090.003).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This retrospective study showed that the adverse outcomes were not different during the COVID-19 pandemic compared to historical control data, suggesting that newly adopted management strategies might provide optimal care for ACS patients. Larger sample sizes and longer follow-up periods on this issue are needed in the future.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12872-022-02680-z","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T10:03:13Z","timestamp":1653472993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management strategies and outcomes of acute coronary syndrome (ACS) during Covid-19 pandemic"],"prefix":"10.1186","volume":"22","author":[{"given":"Mingliang","family":"Zuo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoubo","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjib","family":"Bhattacharyya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chungwah","family":"Siu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"2680_CR1","doi-asserted-by":"publisher","first-page":"585354","DOI":"10.3389\/fimmu.2020.585354","volume":"11","author":"O Sharma","year":"2020","unstructured":"Sharma O, Sultan AA, Ding H, et al. A review of the progress and challenges of developing a vaccine for COVID-19. Front Immunol. 2020;11:585354.","journal-title":"Front Immunol"},{"issue":"3","key":"2680_CR2","first-page":"189","volume":"48","author":"Chinese Society of Cardiology of Chinese Medical Association","year":"2020","unstructured":"Chinese Society of Cardiology of Chinese Medical Association. Expert consensus on principal of clinical management of patients with severe emergent cardiovascular diseases during the epidemic period of COVID-19. Chin J Cardiol. 2020;48(3):189\u201394.","journal-title":"Chin J Cardiol"},{"issue":"24","key":"2680_CR3","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1056\/NEJMms2009984","volume":"382","author":"L Rosenbaum","year":"2020","unstructured":"Rosenbaum L. The untold toll\u2014the pandemic\u2019s effects on patients without Covid-19. N Engl J Med. 2020;382(24):2368\u201371.","journal-title":"N Engl J Med"},{"issue":"1","key":"2680_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1056\/NEJMc2009166","volume":"383","author":"O De Filippo","year":"2020","unstructured":"De Filippo O, D\u2019Ascenzo F, Angelini F, et al. Reduced rate of hospital admissions for ACS during Covid-19 outbreak in Northern Italy. N Engl J Med. 2020;383(1):88\u20139.","journal-title":"N Engl J Med"},{"key":"2680_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ahj.2020.04.022","volume":"226","author":"HK Abdelaziz","year":"2020","unstructured":"Abdelaziz HK, Abdelrahman A, Nabi A, et al. Impact of COVID-19 pandemic on patients with ST-segment elevation myocardial infarction: insights from a British cardiac center. Am Heart J. 2020;226:45\u20138.","journal-title":"Am Heart J"},{"key":"2680_CR6","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1093\/eurheartj\/ehaa409","volume":"41","author":"S De Rosa","year":"2020","unstructured":"De Rosa S, Spaccarotella C, Basso C, et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. Eur Heart J. 2020;41:2083\u20138.","journal-title":"Eur Heart J"},{"key":"2680_CR7","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.jacc.2020.04.011","volume":"75","author":"S Garcia","year":"2020","unstructured":"Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2871\u20132.","journal-title":"J Am Coll Cardiol"},{"key":"2680_CR8","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1093\/eurheartj\/ehaa314","volume":"41","author":"B Metzler","year":"2020","unstructured":"Metzler B, Siostrzonek P, Binder RK, et al. Decline of acute coronary syndrome admissions in Austria since the outbreak of COVID-19: the pandemic response causes cardiac collateral damage. Eur Heart J. 2020;41:1852\u20133.","journal-title":"Eur Heart J"},{"issue":"24","key":"2680_CR9","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1161\/CIRCULATIONAHA.120.047457","volume":"141","author":"R Piccolo","year":"2020","unstructured":"Piccolo R, Bruzzese D, Mauro C, et al. Population trends in rates of percutaneous coronary revascularization for acute coronary syndromes associated with the COVID-19 outbreak. Circulation. 2020;141(24):2035\u20137.","journal-title":"Circulation"},{"issue":"2","key":"2680_CR10","doi-asserted-by":"publisher","first-page":"E194","DOI":"10.1002\/ccd.28943","volume":"97","author":"CF Tam","year":"2021","unstructured":"Tam CF, Cheung KS, Lam S, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China. Catheter Cardiovasc Interv. 2021;97(2):E194\u20137.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"2680_CR11","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1007\/s00134-020-05993-9","volume":"46","author":"J Zeng","year":"2020","unstructured":"Zeng J, Huang J, Pan L. How to balance acute myocardial infarction and COVID-19: the protocols from Sichuan Provincial People\u2019s Hospital. Intensive Care Med. 2020;46(6):1111\u20133.","journal-title":"Intensive Care Med"},{"issue":"3","key":"2680_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cnc.2016.04.006","volume":"28","author":"MG Carey","year":"2016","unstructured":"Carey MG. Acute coronary syndrome and ST segment monitoring. Crit Care Nurs Clin N Am. 2016;28(3):347\u201355.","journal-title":"Crit Care Nurs Clin N Am"},{"issue":"23","key":"2680_CR13","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/eurheartj\/ehaa035","volume":"41","author":"TS Hartikainen","year":"2020","unstructured":"Hartikainen TS, S\u00f6rensen NA, Haller PM, et al. Clinical application of the 4th universal definition of myocardial infarction. Eur Heart J. 2020;41(23):2209\u201316.","journal-title":"Eur Heart J"},{"issue":"21","key":"2680_CR14","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1136\/heartjnl-2015-307691","volume":"101","author":"M Barnes","year":"2015","unstructured":"Barnes M, Heywood AE, Mahimbo A, et al. Acute myocardial infarction and inflfluenza: a meta-analysis of case-control studies. Heart. 2015;101(21):1738\u201347.","journal-title":"Heart"},{"issue":"1","key":"2680_CR15","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jacc.2020.04.029","volume":"76","author":"JN Katz","year":"2020","unstructured":"Katz JN, Sinha SS, Alviar CL, et al. COVID-19 and disruptive modifications to cardiac critical care delivery: JACC review topic of the week. J Am Coll Cardiol. 2020;76(1):72\u201384.","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"2680_CR16","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.jacc.2020.04.011","volume":"75","author":"S Garcia","year":"2020","unstructured":"Garcia S, Albaghdadi MS, Meraj PM, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol. 2020;75(22):2871\u20132.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2680_CR17","doi-asserted-by":"publisher","first-page":"e006631","DOI":"10.1161\/CIRCOUTCOMES.120.006631","volume":"13","author":"CF Tam","year":"2020","unstructured":"Tam CF, Cheung KS, Lam S, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment-elevation myocardial infarction care in Hong Kong, China. Circ Cardiovasc Qual Outcomes. 2020;13(4):e006631.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"2","key":"2680_CR18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ccd.28997","volume":"97","author":"TA Hammad","year":"2021","unstructured":"Hammad TA, Parikh M, Tashtish N, et al. Impact of COVID-19 pandemic on ST-elevation myocardial infarction in a non-COVID-19 epicenter. Catheter Cardiovasc Interv. 2021;97(2):208\u201314.","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"2680_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1253\/circj.CJ-20-0800","volume":"85","author":"NW Chew","year":"2021","unstructured":"Chew NW, Sia CH, Wee HL, et al. Impact of the COVID-19 pandemic on door-to-balloon time for primary percutaneous coronary intervention\u2014results from the Singapore Western STEMI network. Circ J. 2021;85(2):139\u201349.","journal-title":"Circ J"},{"issue":"8","key":"2680_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1080\/00015385.2020.1796035","volume":"76","author":"MJ Claeys","year":"2021","unstructured":"Claeys MJ, Argacha JF, Collart P, et al. Impact of COVID-19-related public containment measures on the ST elevation myocardial infarction epidemic in Belgium: a nationwide, serial, cross-sectional study. Acta Cardiol. 2021;76(8):863\u20139.","journal-title":"Acta Cardiol"},{"issue":"18","key":"2680_CR21","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.jacc.2020.03.021","volume":"75","author":"FGP Welt","year":"2020","unstructured":"Welt FGP, Shah PB, Aronow HD, et al. Catheterization laboratory considerations during the coronavirus (COVID-19) pandemic: from ACC\u2019s Interventional Council and SCAI. J Am Coll Cardiol. 2020;75(18):2372\u20135.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2680_CR22","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3390\/jcm10010024","volume":"10","author":"P Tou\u0161ek","year":"2020","unstructured":"Tou\u0161ek P, Kocka V, Masek P, et al. Modified strategies for invasive management of acute coronary syndrome during the COVID-19 pandemic. J Clin Med. 2020;10(1):24.","journal-title":"J Clin Med"},{"issue":"7","key":"2680_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11883-020-00849-5","volume":"22","author":"A Giordano","year":"2020","unstructured":"Giordano A, Biondi-Zoccai G, Frati G, et al. Management of structural heart disease and acute coronary syndromes in the COVID-19 pandemic. Curr Atheroscler Rep. 2020;22(7):29.","journal-title":"Curr Atheroscler Rep"},{"issue":"13","key":"2680_CR24","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1093\/eurheartj\/ehy004","volume":"39","author":"KH Scholz","year":"2018","unstructured":"Scholz KH, Maier SKG, Maier LS, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39(13):1065\u201374.","journal-title":"Eur Heart J"},{"issue":"24","key":"2680_CR25","doi-asserted-by":"publisher","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.120.047122","volume":"141","author":"MJ Daniels","year":"2020","unstructured":"Daniels MJ, Cohen MG, Bavry AA, et al. Reperfusion of STEMI in the COVID-19 era\u2014business as usual? Circulation. 2020;141(24):1948\u201350.","journal-title":"Circulation"},{"issue":"4","key":"2680_CR26","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.amjcard.2018.04.057","volume":"122","author":"TJ Siddiqi","year":"2018","unstructured":"Siddiqi TJ, Usman MS, Khan MS, et al. Meta-analysis comparing primary percutaneous coronary intervention versus pharmacoinvasive therapy in transfer patients with ST-elevation myocardial infarction. Am J Cardiol. 2018;122(4):542\u20137.","journal-title":"Am J Cardiol"},{"issue":"10","key":"2680_CR27","first-page":"1133","volume":"19","author":"F Bedn\u00e1r","year":"2003","unstructured":"Bedn\u00e1r F, Widimsk\u00fd P, Krupicka J, et al. Interhospital transport for primary angioplasty improves the long-term outcome of acute myocardial infarction compared with immediate thrombolysis in the nearest hospital (one-year follow-up of the PRAGUE-1 study). Can J Cardiol. 2003;19(10):1133\u20137.","journal-title":"Can J Cardiol"},{"issue":"13","key":"2680_CR28","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1136\/heartjnl-2014-306966","volume":"101","author":"I Ranasinghe","year":"2015","unstructured":"Ranasinghe I, Barzi F, Brieger D, et al. Long-term mortality following interhospital transfer for acute myocardial infarction. Heart. 2015;101(13):1032\u201340.","journal-title":"Heart"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02680-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02680-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02680-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T10:03:41Z","timestamp":1653473021000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02680-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2680"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02680-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,25]]},"assertion":[{"value":"3 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki for Human Research and was approved by the ethics committee of Sichuan Academy of Medical Science & Sichuan Provincial People\u2019s Hospital. This retrospective study was based on a single hospital registry of ACS in Sichuan Provincial People's Hospital, Chengdu, Sichuan, China. The study protocol was approved by the local Institutional Review Board. Informed consent from patients was not necessary given the registered nature of the study; nonetheless all patient records\/information were anonymous prior to analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"242"}}